Wednesday, August 11, 2021 8:23:04 AM
FeMike, here ya go, your own words....
"There are countless reasons.
The data could be inconclusive and they could be lobbying for approval amidst 'meh' data.
They could be needing a finance soon and know that this sort of public appearance would boost the stock price.
I don't think these are the reasons but please don't be naïve enough to think that the title of this lunch presentation in any way shape or form means TLD is positive.
Have you taken out a second mortgage on your house? Have you gotten every payday advance loan you can get? Have you cashed out your 401k to put it all into NWBO?
If there is no other explanation for the title of this presentation than positive TLD, then you should have already done these things by now to invest 100% of your net worth into NWBO. If you haven't done these things, then you concede that there is a chance that maybe the title isn't 100% proof that TLD is positive and there are indeed other reasons for NWBio to hold this sponsorship."
"There are countless reasons.
The data could be inconclusive and they could be lobbying for approval amidst 'meh' data.
They could be needing a finance soon and know that this sort of public appearance would boost the stock price.
I don't think these are the reasons but please don't be naïve enough to think that the title of this lunch presentation in any way shape or form means TLD is positive.
Have you taken out a second mortgage on your house? Have you gotten every payday advance loan you can get? Have you cashed out your 401k to put it all into NWBO?
If there is no other explanation for the title of this presentation than positive TLD, then you should have already done these things by now to invest 100% of your net worth into NWBO. If you haven't done these things, then you concede that there is a chance that maybe the title isn't 100% proof that TLD is positive and there are indeed other reasons for NWBio to hold this sponsorship."
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
